Solid Dispersion Technique to Enhance the Solubility of Poorly Water-Soluble Drugs

Document Type : compile

Authors

1 -

2 Iran polymer and petrochemical institute

Abstract

The solubility and permeability of drugs are the most important biopharmaceutical properties that affect their bioavailability. In the biopharmaceutics classification system (BCS), there are a large number of active pharmaceutical ingredients (APIs) with low solubility (BCS classes II and IV) that are rarely offered to the market. Therefore, it is necessary to provide a solution to increase thier solubility. There are many preparation methods to enhance the solubility and dissolution rate of drugs and thereby absorption in the gastrointestinal tract. Among them, the solid dispersion method is considered one of the most important methods. Since 1960s, the development of pharmaceutical formulations based on the solid dispersion method has undergone significant progress. Solvent-based and melting methods can be mentioned for the preparation of drug-containing systems. The use of different substrates from a single polymeric carrier to multiple carriers containing emulsifier in the design of solid dispersion formulations has led to the improvement of the stability and performance of these systems. In this article, the solid dispersion technique for the preparation of pharmaceutical formulations is introduced, and also a summary of the preparation methods and the recent advances in this field are briefly reviewed.
 

Keywords

Main Subjects

References

  1. Tambe S., Jain D., Meruva S.K., Rongala G., Juluri A., Nihalani G., and Mamidi H.K., Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization, Pharmaceutics, 14, 2203, 2022.
  2. Kanikkannan N., Technologies to Improve the Solubility, Dissolution and Bioavailability of Poorly Soluble Drugs, J. Anal. Pharm. Res., 7, 00198, 2018.
  3. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R., A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm. Res., 12, 413–420, 1995.
  4. Rautio J., Kumpulainen H., Heimbach T., Oliyai R., Oh D., Järvinen T., and Savolainen J., Prodrugs: Design and Clinical Applications, Nat. Rev. Drug Discov., 7, 255-270, 2008.
  5. Dressman J.B. and Reppas C., In Vitro-In Vivo Correlations for Lipophilic, Poorly Water Soluble Drugs, Eur. J. Pharm. Sci., 11, S73-80, 2000.
  6. Tekade A.R. and Yadav J.N., A Review on Solid Dispersion and Carriers Used Therein for Solubility Enhancement of Poorly Water Soluble Drugs, Adv. Pharm. Bull., 10, 359-369, 2020.
  7. Ainurofiq A., Putro DS., Ramadhani DA., Putra GM., and Do Espirito Santo LDC., A Review on Solubility Enhancement Methods for Poorly Water-Soluble Drugs, J. Rep. Pharm. Sci., 10, 137-47, 2021.
  8. Vasconcelos T., Sara Marques S., Neves J., and Sarmento B., Amorphous Solid Dispersions: Rational Selection of a Manufacturing Process, Adv. Drug Deliv. Rev., 100, 85–101, 2016.
  9. Sekiguchi K. and Obi N., Studies on Absorption of Eutectic Mixtures. I. A Comparison of the Behavior of Eutectic Mixtures of Sulphathiazole and that of Ordinary Sulphathiazole in Man, Chem. Pharm. Bull., 9, 866-72, 1961.
  1. Chiou W.L. and Riegelman S., Pharmaceutical Applications of Solid Dispersion Systems, J. Pharm. Sci., 60, 1281-1302, 1971.
  2. Zhang X., Xing H., Zhao Y., and Ma Z., Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs, Pharmaceutics, 10, 74, 2018.
  1. Malkawi R., Malkawi W.I., Al-Mahmoud Y., and Tawalbeh J., Current Trends on Solid Dispersions: Past, Present, and Future, Adv. Pharmacol. Pharm. Sci., Article ID 5916013, 2022.
  2. Qian F., Huang J., and Hussain M.A., Drug–Polymer Solubility and Miscibility: Stability Consideration and Practical Challenges in Amorphous Solid Dispersion Development, J. Pharm. Sci., 99, 2941-2947, 2010.
  1. Karolewicz B., Górniak A., Owczarek A., Nartowski K., Zurawska-Płaksej E., and Pluta J., Solid Dispersion in Pharmaceutical Technology. Part II. The Methods of Analysis of Solid Dispersions and Examples of their Application, Polim. Med., 42, 97-107, 2012.
  1. Nair A.R., Lakshman Y.D., Krishna Anand V.S., Sree K.S.N., Bhat K., and Dengale S.J., Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology, AAPS Pharm. Sci. Technol., 21, 1-20, 2020.
  2. Kurmi R., Mishra D.K., and Jain D.K., Solid Sispersion: A Novel Means of Solubility Enhancement, J. Crit. Rev., 3, 1-8, 2016.
  3. Cid A.G., Simonazzi A., Palma S.D., and Bermudez J.M., Solid Dispersion Technology as a Strategy to Improve the Bioavailability of Poorly Soluble Drugs, Ther. Deliv., 10, 363–382, 2019.
  4. Suzuki H., Yakushiji K., Matsunaga S., Yamauchi Y., Seto Y., Sato H., and Onoue S., Amorphous Solid Dispersion of Meloxicam Enhanced Oral Absorption in Rats with Impaired Gastric Motility, J. Pharm. Sci., 107, 446–452, 2018.
  1. Tan D.K., Davis Jr D.A., Miller D.A., Williams III R.O., and Nokhodchi A., Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing, AAPS Pharm. Sci. Technol., 21, 1-20, 2020.
  2. Zhang S., Lee T.W.Y., and Chow A.H.L., Thermodynamic and Kinetic Evaluation of the Impact of Polymer Excipients on Storage Stability of Amorphous Itraconazole, Int. J. Pharm., 555, 394-403, 2019.
  1. Shaker M.A., Elbadawy H.M., and Shaker M.A., Improved Solubility, Dissolution, and Oral Bioavailability for Atorvastatin-Pluronic® Solid Dispersions, Int. J. Pharm., 118891, 2019.
  2. Smeets A., Koekoekx R., Ruelens W., Smet M., Clasen C., and van den Mooter G., Gastro-resistant Encapsulation of Amorphous Solid Dispersions Containing Darunavir by Coaxial Electrospraying, Int. J. Pharm., 118885, 2019.
  3. Costa B., Sauceau M., Del Confetto S., Sescousse R., and Ré M.I., Determination of Drug-Polymer Solubility from Supersaturated Spray-Dried Amorphous Solid Dispersions: A Case study with Efavirenz and Soluplus®, Eur. J. Pharm. Biopharm., 142, 300-306, 2019.
  4. Mathers A., Hassouna F., Malinova L., Merna J., Růžička K., and Fulem M., Impact of Hot-Melt Extrusion Processing Conditions on Physicochemical Properties of Amorphous Solid Dispersions Containing Thermally Labile Acrylic Copolymer, J. Pharm. Sci., 109, 1008-1019, 2019.
  5. Kawakami K., Suzuki K., Fukiage M., Matsuda M., Nishida Y., Oikawa M., and Fujita T., Impact of Degree of Supersaturation on the Dissolution and Oral Absorption Behaviors of Griseofulvin Amorphous Solid Dispersions, J. Drug Del. Sci. Technol. B, 56, 101172, 2019.
  6. Xie Y. and Yao Y., Incorporation with Dendrimer-Like Biopolymer Leads to Improved Soluble Amount and In Vitro Anticancer Efficacy of Paclitaxel, J. Pharm. Sci., 108, 1984– 1990, 2019.
  7. Silva de Sá I., Peron A.P., Leimann F.V., Bressan G.N., Krum B.N., Fachinetto R., Pinela J. et al., In Vitro and In Vivo Evaluation of Enzymatic and Antioxidant Activity, Cytotoxicity and Genotoxicity of Curcumin-loaded Solid Dispersions, Food Chem. Toxicol., 125, 29–37, 2019.
  1. Xiong X., Zhang M., Hou Q., Tang P., Suo Z., Zhu Y., and Li H., Solid Dispersions of Telaprevir with Improved Solubility Prepared by Co-milling: Formulation, Physicochemical Characterization, and Cytotoxicity Evaluation, Mater. Sci. Eng. C., 105, 110012, 2019.
  1. Simonazzi A., Davies C., Cid A.G., Gonzo E., Parada L., and Bermudez J.M., Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance, J. Pharm. Sci., 107, 2829–2836, 2018.

Files

Share

How to cite

Statistics